Company Filing History:
4 out of 1,217 
4 out of 5 
3 out of 3,446 
Years Active: 1996-2022
Title: Innovations by Peter L Nara: Pioneering Influenza Immunogens
Introduction
Peter L Nara is a prominent inventor based in Frederick, MD, United States, known for his contributions to the field of immunology. With a remarkable portfolio of 12 patents, Nara has been at the forefront of developing novel compositions that enhance immune responses, particularly against influenza.
Latest Patents
Among his latest innovations is the "Immunogenic influenza composition," which provides methods for creating novel compositions useful as influenza immunogens. These compositions enable a host response to immunogen sites not normally recognized by the immune system. The innovative immunogens developed by Nara can be utilized as vaccines or to generate effective antibodies, potentially transforming the approach to flu prevention and treatment.
Career Highlights
Peter L Nara has made significant strides in his career, contributing to various projects that aim to address public health challenges through advanced immunological research. He has worked with the United States of America as represented by the Department of Health, where his groundbreaking work in vaccine development has had a considerable impact.
Collaborations
Throughout his career, Nara has collaborated with notable individuals such as Jay A. Berzofsky and Jeffrey D. Ahlers, further enhancing the scope and effectiveness of his research endeavors. These collaborations have allowed for a rich exchange of ideas and expertise, leading to innovations that push the boundaries of current scientific understanding.
Conclusion
Peter L Nara's work exemplifies the significant role inventors play in developing solutions to complex health issues. His innovative approaches to influenza immunization are paving the way for future advancements, highlighting the importance of continued research and collaboration in the field of immunology. With a commitment to excellence, Nara's contributions will undoubtedly leave a lasting legacy in the realm of medical science.